Beam Therapeutics (BEAM) Total Debt: 2019-2025
Historic Total Debt for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to $6.5 million.
- Beam Therapeutics' Total Debt fell 22.62% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 22.62%. This contributed to the annual value of $8.4 million for FY2024, which is 22.22% down from last year.
- Latest data reveals that Beam Therapeutics reported Total Debt of $6.5 million as of Q3 2025, which was up 66.67% from $3.9 million recorded in Q2 2025.
- Beam Therapeutics' Total Debt's 5-year high stood at $85.4 million during Q2 2021, with a 5-year trough of $3.9 million in Q2 2025.
- For the 3-year period, Beam Therapeutics' Total Debt averaged around $9.1 million, with its median value being $8.4 million (2024).
- Per our database at Business Quant, Beam Therapeutics' Total Debt skyrocketed by 596.19% in 2021 and then plummeted by 80.80% in 2022.
- Over the past 5 years, Beam Therapeutics' Total Debt (Quarterly) stood at $42.2 million in 2021, then slumped by 56.64% to $18.3 million in 2022, then tumbled by 40.98% to $10.8 million in 2023, then decreased by 22.22% to $8.4 million in 2024, then decreased by 22.62% to $6.5 million in 2025.
- Its Total Debt was $6.5 million in Q3 2025, compared to $3.9 million in Q2 2025 and $5.2 million in Q1 2025.